In mammals, liver is a central organ for controlling the metabolic homeostasis for
carbohydrates, lipid, and proteins. Dysregulation of liver functions could lead to the …

Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological change characterized by
the accumulation of triglycerides in hepatocytes and has frequently been associated with …

Growing epidemiological evidence suggests that nonalcoholic fatty liver disease (NAFLD) is
an early predictor of and determinant for the development of type 2 diabetes and other …

Obesity is associated with an increased risk of nonalcoholic fatty liver disease (NAFLD).
Steatosis, the hallmark feature of NAFLD, occurs when the rate of hepatic fatty acid uptake …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver
disease affecting both adults and children in the United States and many other parts of the …

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease that occurs in nondrinkers
but which cannot be distinguished from alcohol-induced liver disease histologically. There …

Non-alcoholic fatty liver disease (NAFLD) represents a wide spectrum of diseases, ranging
from simple fatty liver (hepatic steatosis) through steatosis with inflammation and necrosis to …

The steady rise in Western obesity rates has been closely linked to significant increases in a
multitude of accompanying health problems including non-alcoholic fatty liver disease …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized pathology with a
high prevalence and a possible evolution to its inflammatory counterpart (non-alcoholic …

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic lipid accumulation in
the absence of excess alcohol intake. NAFLD is the most common chronic liver disease, and …